Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |